Galera Therapeutics, Inc.
GRTX
$0.02
$0.00-6.62%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.47M | 5.23M | 6.69M | 8.29M | 8.46M |
| Total Receivables | -- | -- | -- | 635.00K | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 428.00K | 717.00K | 874.00K | 1.08M | 444.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 4.90M | 5.95M | 7.56M | 10.00M | 8.90M |
|
|
|||||
| Total Current Assets | 4.90M | 5.95M | 7.56M | 10.00M | 8.90M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 101.00K | 101.00K | 101.00K | 100.00K | 2.00K |
| Total Assets | 5.00M | 6.05M | 7.66M | 10.10M | 8.90M |
|
|
|||||
| Total Accounts Payable | 434.00K | 202.00K | 744.00K | 1.28M | 296.00K |
| Total Accrued Expenses | 164.00K | 145.00K | 231.00K | 391.00K | 618.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 598.00K | 347.00K | 975.00K | 1.67M | 914.00K |
|
|
|||||
| Total Current Liabilities | 598.00K | 347.00K | 975.00K | 1.67M | 914.00K |
| Long-Term Debt | 151.05M | 151.05M | 151.05M | 151.05M | 151.05M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 1.06M | -- |
| Total Liabilities | 151.65M | 151.40M | 152.02M | 153.77M | 151.96M |
|
|
|||||
| Common Stock & APIC | 311.20M | 311.09M | 310.73M | 308.32M | 308.37M |
| Retained Earnings | -460.42M | -459.03M | -457.96M | -456.36M | -451.43M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -149.22M | -147.95M | -147.23M | -148.04M | -143.06M |
|
|
|||||
| Preferred Stock Redeemable | 2.58M | 2.60M | 2.86M | 4.37M | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 2.58M | 2.60M | 2.86M | 4.37M | -- |
|
|
|||||
| Total Common Equity | -149.22M | -147.95M | -147.23M | -148.04M | -143.06M |
| Total Preferred Equity | 2.58M | 2.60M | 2.86M | 4.37M | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -146.65M | -145.35M | -144.36M | -143.67M | -143.06M |
|
|
|||||